Financials — DANA-FARBER CANCER INSTITUTE
3-statement model reconstructed from HCRIS + deal profile
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
Income Statement
| Line Item | Amount |
|---|---|
| Gross Patient Revenue estimated | $4.2B |
| Contractual Allowances estimated | $-2.3B |
| Net Patient Revenue deal_profile | $1.9B |
| Bad Debt Expense benchmark 3% | $-56.5M |
| Total Operating Revenue computed | $1.8B |
| Salaries & Wages benchmark 55% opex | $-953.1M |
| Supplies benchmark 18% opex | $-311.9M |
| Other Operating residual | $-467.9M |
| Total Operating Expenses estimated | $-1.7B |
| EBITDA computed | $94.2M |
| D&A benchmark 4% NPR | $-75.3M |
| EBIT computed | $18.8M |
| Interest benchmark 2% NPR | $-37.7M |
| EBT computed | $-18.8M |
| Taxes 25% rate | $0.0M |
| Net Income computed | $-18.8M |
Balance Sheet
| Line Item | Amount |
|---|---|
| Cash benchmark 45 days | $232.2M |
| A/R deal_profile | $158.0M |
| Inventory benchmark 15 days | $77.4M |
| Other Current benchmark 2% | $37.7M |
| Total Current Assets computed | $505.3M |
| PP&E Net benchmark 60% NPR | $1.1B |
| Other Assets benchmark 5% | $94.2M |
| Total Assets computed | $1.7B |
| A/P benchmark 40 days | $189.9M |
| Accrued Liab benchmark 6% opex | $104.0M |
| Current Debt benchmark 5% total debt | $16.5M |
| Total Current Liab computed | $310.4M |
| LT Debt benchmark 3.5x EBITDA | $313.2M |
| Total Liabilities computed | $623.5M |
| Total Equity plug (A - L) | $1.1B |
| Total L + E computed | $1.7B |
What This Means
This 3-statement model reconstructs the hospital's income statement, balance sheet, and cash flow from HCRIS cost report data. Each line item is tagged with its data source: HCRIS (actual reported), deal_profile (user input), benchmark (industry estimate), computed (derived).
Use this to identify data quality: lines tagged "benchmark" are estimates that should be validated during diligence. Request actual data for these items via diligence questions.
Cash Flow Statement
| Line Item | Amount |
|---|---|
| Net Income computed | $-18.8M |
| + D&A from IS | $75.3M |
| Change in A/R 3% growth | $-4.7M |
| Change in Inventory 2% growth | $-1.5M |
| Change in A/P 2% growth | $3.8M |
| CFO computed | $54.0M |
| CapEx benchmark 4% NPR | $-75.3M |
| CFI computed | $-75.3M |
| Debt Repayment 5% of LT debt | $-15.7M |
| CFF computed | $-15.7M |
| Net Change computed | $-37.0M |
| FCF CFO - CapEx | $-21.3M |